To investigate if defects in MTO1 cause the hypertrophic cardiomyopathy in vivo, we generated the mto1 knock-out (KO) zebrafish produced by genome editing using the CRISPR/Cas9 system (47). The gene discussed is MTO1; the disease is hypertrophic cardiomyopathy.